Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News After The Close

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Sep 25, 2024 10:39pm

81 Views

Post# 36241483

RE:RE:RE:RE:RE:RE:RE:RE:RE:News After The Close

With 34 million warrants, if SP hits over 50 cents, most should get excercised bringing in about $10 Million cash. Warrants are priced at 25, 28, 30 and 35 cents. IMHO

2b7f6fab wrote: You need to keep in mind that the 12 million options granted were to replace the 10 million options that expired a week or two ago. Of course mgmt is going to replace them. That's how the game works. If you don't understand that you shouldn't be investing. Current share count is approximately 240 million share o/s, 20 million options and 34 million warrants. Fully diluted just under 300 million. Yus got to due diligence.

So imagine for a moment you're an investment banker with $100 millions dollars to work with. You'd like to put $10 million into TLT with a market cap of only $40 million, but you want BTD first. Problem is when BTD comes the market cap probably won't be so low anymore and you won't be the only one wanting a piece of it, retail, hedge funds, Pfizer, Merck, pony up and get in line.

Alamir1111 wrote: That's a good assesment

The directors of the Company have agreed to grant an aggregate of 12,340,000 stock options to directors, officers and employees pursuant to the Company's stock option plan. The options granted are exercisable at a price of $CAN 0.25 per common share, vest over a three-years period and expire five years from the date of the grant.